 |
|
| Blog results | Results 1 - 10 of about 6,044 for tamoxifen and raloxifene. (0.29 seconds) |
| Sorted by relevance Sort by date |
| 29 Oct 2009 by Legault, Maki, Resnick, Coker, Hogan, Bevers,... Patients and Methods The National Surgical Adjuvant Breast and Bowel Project's Study of Tamoxifen and Raloxifene (STAR) study was a randomized clinical trial of tamoxifen 20 mg/d or raloxifene 60 mg/d in healthy postmenopausal women at ... Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/ [ More results from Journal of Clinical Oncology Current Issue ] |
| 5 Dec 2009 Raloxifene, too, has been shown to be cross-resistant to tamoxifen in Phase II trials of second-line treatment of advanced breast cancer (Buzdar et al., 1988) and appears to have equal efficacy to existing hormonal agents as first-line ... Clinics Turkey.com Health Advice and News - http://www.clinicsturkey.com/ |
| 13 Nov 2009 by Margaret Polaneczky, MD (aka TBTAM) Both tamoxifen and raloxifene cut the risk for breast cancer in half among high risk women who use the drug for 5 years. Tamoxifen also prevents DCIS and LCIS in addition to invasive cancer, while raloxifene does not reduce these risks. ... The Blog that Ate Manhattan - http://theblogthatatemanhattan.blogspot.com/ - References |
| 28 Nov 2009 by Freelancer jobs Need about 800 word article on tamoxifen, calcitonin, and raloxifene drugs that are used for treatment of osteoporosis. (800 words is total for all three drugs). Please mention typical dosages, regimens, side effects, who is most likely ... Freelancer jobs resources - http://www.freelancer-job.com/jobs/ |
| 3 Dec 2009 by Mehment Oz Tamoxifen and a similar drug called raloxifene do cut risk, but so far haven't been proven to prevent deaths from breast cancer. Neither has finasteride, a drug that can reduce prostate cancer cases by 25 percent. ... Washington Examiner Site Feed - http://www.washingtonexaminer.com/templates/rss |
| 16 Nov 2009 by David Gorski And as for your endorsement of tamoxifen and raloxifene for breast cancer prevention, while there's no doubt it is beneficial for women at high-risk, there's no effort to in her story or your post to compare the benefits of those drugs ... Science-Based Medicine - http://www.sciencebasedmedicine.org/ - References |
| 2 Nov 2009 by Kondo, M., Hoshi, S.-L., Toi, M. Budget Impact Analysis of Chemoprevention of Breast Cancer with Tamoxifen and Raloxifene among High-risk Women in Japan. Masahide Kondo1,2, Shu-Ling Hoshi1 and Masakazu Toi3. 1 Department of Health Care Policy and Management, ... Japanese Journal of Clinical Oncology -... - http://jjco.oxfordjournals.org/ |
| 17 Nov 2009 A systematic review carried out on behalf of the US Agency for Healthcare Research and Quality (AHRQ) concludes that tamoxifen, raloxifene, and tibolone can reduce the risk of primary breast cancer, however all are also associated with ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ |
| 18 Nov 2009 by Dr.Shruti Bhat In fact, tamoxifen and raloxifene boosted blood clots by 60 percent to 90 percent. Tamoxifen was also more likely than a placebo to lead to endometrial cancer and more likely to cause cataracts than was raloxifene. ... Pharmacy Education And Research .Com - http://www.pharm-education.com/ |
| 1 Dec 2009 It found that tamoxifen increases risk for endometrial cancer, hysterectomies, and cataracts compared with the other drugs. Tamoxifen and raloxifene increase risk of blood clots, although tamoxifen's risk is greater. ... Nurse.com News - http://www.nurse.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
